Mathews Journal of Cytology and Histology (MJCH; ISSN 2577-4158) is a scholarly journal that publishes high-quality research that emphasizes clinicopathological correlations in an environment that is patient-centered, technological advancements in basic and translational research with particular emphasis on the development of personalized medicine, and novel or improved molecular techniques and their applications in diagnosis or disease monitoring. Such research touches on a variety of topics, such as cytology, cytopathology, cytogenetics, cytometry, cytotechnology, histology, histopathology, cell growth, cell biology, cell physiology, cell signaling, Cell Adhesion, neurocytology, cytotoxicity, cell fractionation, cellular microbiology, immunofluorescence, and immunohistochemistry.
Preference is also given to scholarly works dealing with new innovative tools aimed at educating medical personnel and at designing and implementing newer assessment and evaluation strategies. This journal duly addresses and highlights issues pertaining to population health and public policy making. This bimonthly journal intends to be a flag-bearer in cytology/histology research by establishing professional quality standards, thereby ensuring diagnostic excellence; advocating laboratory quality and safety; advocating inter-professional education for pathologists, cytologists and allied health care professionals.
Why publish with us?
High Visibility: The open-access format followed by MJCH allows for global dissemination of the published articles.
Promotion in Social Media: Once an article is published online, readers are provide with article alerts and regular email updates through our social media platforms.
Rigorous peer review: Every manuscript submitted undergoes a thorough and rigorous double-blind peer-review. This process eliminates subjective judgments and bias from the decision making process.
We welcome all types of articles related to Cytology and Histology. For submission assistance contact: i[email protected]. Please follow the Author Guidelines.
If you are not sure whether your work is suitable for this journal, please email us at i[email protected] or call us at +1-606-405–6566.
Published : 22nd November 2023
Authors : George UU1, Mbong EO2, Abiaobo NO3, Akpan II3
Citation : George UU, et al. (2023). In Vivo Studies on Mortality and Histopathological Indices of Phragmenthera capitata (Mistletoes) on Clarias gariepinus Fingerglings in Aquarium. Mathews J Cytol Histol. 7(2):25.
Published : 14th November 2023
Authors : Amir Nejad-Moghaddam1,2,*, Aram Asareh Zadegan Dezfuli3, Saeed Rahmanzadeh4
Citation : Nejad-Moghaddam A, et al. (2023). The Role of Mesenchymal Stem Cells in Modulating the Immune System and Repairing Lung Damage in ARDS Patients with SARS-COV-2. Mathews J Cytol Histol. 7(2):24.
Published : 21st October 2023
Authors : Mwesigwa Boaz1,*, Mawanda Anatoli1,2, Nasozi Ruth1, Caroline Achola1,4, Amuge Marion Sheilla3
Citation : Boaz M. (2023). The Crucial Role of Circulating Tumor Cells in Cervical Cancer Diagnosis. Mathews J Cytol Histol. 7(2):23.
Published : 30th March 2023
Authors : Mehmet Rami Helvaci1,*, Ali Rıza Ozer2, Esra Candan2, Ismihan Sahin2, Abdulrazak Abyad3, Lesley Pocock4
Citation : Helvaci MR, et al. (2023). Sickle Cell Diseases May Show Terminal Consequences of the Metabolic Syndrome in Much Earlier Ages. Mathews J Cytol Histol. 7(1):22.
Published : 16th December 2022
Authors : Kulvinder Kochar Kaur1,*, Gautam Nand Allahbadia2, Mandeep Singh3
Citation : Kaur KK, et al. (2022). An Update on Mechanistic Modes in AGEs Stimulated & ER and Inflammatory Stress-Modulated Control of the GLUT4 expression (SLC2A4 promoted) and Atherogenesis in Diabetes Mellitus-A Narrative Review. Mathews J Cytol Histol. 6(1):21.
Published : 30th November 2022
Authors : Bon Elizaveta Igorevna1,*, Gaiko Diana Vitalievna2, Bakush Ulyana Aleksandrovna3
Citation : Bon EI, et al. (2022). Modeling of Tumor Growth in Experiment. Mathews J Cytol Histol. 6(1):20.